Human Monoclonal Antibodies for SARS-CoV-2 S1
Twist anti-SARS-CoV-2 S1 Antibodies
Twist Biopharma has developed a set of antibodies that target the SARS-CoV-2 S Spike protein. The Spike protein binds the ACE2 receptor on human cells to facilitate viral entry. Because these antibodies have high affinity to the SARS-CoV-2 Spike Protein they have the potential for dual purpose use for virus neutralization or detection in therapeutic and diagnostic applications, respectively.